Optimizing Flu Vaccine Planning at NorthShore University HealthSystem Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics:

• Vaccine acquisition cost: $12.00–$15.00 per dose (varies by manufacturer/timing).
• Reimbursement rate: Fixed at $14.50 per administration (Exhibit 2).
• Storage/Logistics cost: $1.25 per dose per month (Exhibit 3).
• Waste cost: 100% loss of unused inventory at end of season.

Operational Facts:

• Demand uncertainty: Peak demand fluctuates based on CDC severity forecasts (Paragraph 4).
• Lead time: Orders must be placed in March for October delivery (Paragraph 6).
• Capacity: 8 hospital sites, 70+ clinics; total patient base 350,000 (Exhibit 1).
• Constraint: Single-dose vials vs. multi-dose vials impact storage footprint and spoilage risk (Exhibit 4).

Stakeholder Positions:

• Dr. Arkes (Clinical lead): Prioritizes patient access and safety; favors high inventory levels.
• CFO Office: Prioritizes cost control and reduction of waste (Exhibit 5).

Information Gaps:

• Granular historical demand by specific clinic location (only aggregate data provided).
• Cost of stockouts (lost patient trust or downstream medical costs for flu complications).

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question: How should NorthShore balance the financial risk of inventory waste against the clinical risk of vaccine shortages to optimize seasonal flu immunization?

Structural Analysis:

• Supply Chain Dynamics: The mismatch between the March ordering deadline and the October–February demand window creates a classic newsboy problem.
• Cost Asymmetry: The cost of a lost dose ($15) is significantly lower than the potential cost of an unimmunized patient requiring hospitalization.

Strategic Options:

• Option 1: Aggressive Inventory Buffering. Order 115% of historical peak. Ensures access. Trade-off: High financial waste if the flu season is mild.
• Option 2: Just-In-Time (JIT) Redistribution. Order at 95% of forecast, implement real-time inventory tracking to shift doses between clinics. Trade-off: High operational overhead and labor cost.
• Option 3: Risk-Sharing with Vendors. Negotiate partial return policies for unused doses. Trade-off: Higher per-dose price.

Recommendation: Proceed with Option 2. The organization has the scale to centralize logistics, and the financial risk of waste is a controllable expense compared to the reputational risk of failing to serve the community.

3. Implementation Roadmap (Implementation Specialist)

Critical Path:

• Month 1: Deploy real-time inventory software across all 70+ locations.
• Month 2: Establish a centralized distribution hub to manage inter-clinic transfers.
• Month 3: Finalize vendor contracts with optimized delivery windows.

Key Constraints:

• Data Latency: Clinics currently report usage weekly; this must move to daily to enable effective redistribution.
• Staffing: Administrative burden of tracking and moving inventory may distract clinical staff.

Risk-Adjusted Implementation:

• Adopt a hub-and-spoke model. Keep 20% of stock at a central hub to respond to localized demand surges, reducing the need for inter-clinic movement.
• Build a 5% safety stock buffer specifically for high-risk patient clinics.

4. Executive Review and BLUF (Executive Critic)

BLUF: NorthShore must abandon static, site-level inventory planning. The current approach treats every clinic as an island, resulting in simultaneous stockouts and surpluses. By centralizing 20% of inventory and automating daily usage reporting, the system can reduce waste by 15% while improving service levels. This is an operational, not a clinical, problem. The cost of manual tracking is negligible compared to the $15-per-dose waste penalty.

Dangerous Assumption: The analysis assumes that clinic staff will accurately and timely report usage data. Without a financial incentive or automated scanning, the data will be unreliable, rendering the distribution model moot.

Unaddressed Risks:

• Regulatory Compliance: Moving vaccines between sites requires adherence to temperature-controlled logistics (cold chain). A single failure during transit ruins the entire batch.
• Vendor Reliability: The plan assumes the vendor delivers on schedule. If delivery is delayed, the JIT model fails immediately.

Unconsidered Alternative: Partner with local pharmacy chains (e.g., CVS/Walgreens) to offload low-risk patient vaccinations, allowing NorthShore to focus exclusively on high-risk, chronic-care patients, thereby narrowing the inventory demand profile.

Verdict: APPROVED FOR LEADERSHIP REVIEW.